Acta Medica Iranica 2013. 51(10):736.

5-HT3 receptor antagonists: new promising therapeutic agents in diabetes and its complications.
Reza Rahimian, Shahram Ejtemaei Mehr, Gohar Fakhfouri, Ahmad Reza Dehpour


No Abstract##


No Keywords##

Full Text:



Carvalho F, Marcedo D, Banderia I, Maldonado I, Salles L, Azevedo MF, Rocha MA Jr, Fregoneze JB, De Castroe- Silva E. Central 5-HT3 receptor stimulation by m-CPBG increases blood glucose in rats. Horm Metabol Res 2002;34:55–61.

Heimes K, Feistel B, Verspohl EJ. Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts. Eur J of Pharmacol 2009;624:58–65.

Fakhfouri G, Rahimian R, Ghia JE, Khan WI, Dehpour AR. Impact of 5-HT3 receptor antagonists on peripheral and central diseases. Drug Discov Today 2012;17(13-14):741-7.

Rahimian R, Dehpour AR, Fakhfouri G, Khorramizadehc MR,, Ghiad JE, Seyedabadia M, Caldarellie A, Mousavizadehf K, Forouzandehg M, Ejtemaei Mehr Sh. Tropisetron Upregulates Cannabinoid CB1 Receptors in Cerebellar Granule Cells: Possible Involvement of Calcineurin. Brain Res 2011;1417:1–8.

Norouzi A, Fakhfouri G, Rahimian R. How Can 5-HT3 Receptor Antagonists Exert Analgesic Properties? Acta Med Iran 2012;50(4):225.

Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G, Bondy B, Parsons C, Gilling K, Zieglgänsberger W, Holsboer F, Rupprecht R. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Molecul Psychiatry 2003;8:994–1007.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.